Statistics about Health, Pharma & Medtech in United States
Statistics
- Talphera total equity 2019-2023
- Kymera Therapeutics total equity 2019-2023
- Alt5 Sigma Corp total equity 2019-2023
- Leap Therapeutics net cash 2019-2023
- Stem Holdings, Inc. gross profit 2018-2022
- Larimar Therapeutics net cash 2019-2023
- Lantheus Holdings net cash 2019-2023
- Lexicon Pharmaceuticals liabilities 2019-2023
- Alt5 Sigma Corp total assets 2019-2023
- Lumos Pharma liabilities 2019-2023
- Lantern Pharma liabilities 2019-2023
- Alt5 Sigma Corp net cash 2019-2023
- Lantern Pharma net cash 2019-2023
- Stem Holdings, Inc. revenue 2018-2022
- Alt5 Sigma Corp gross profit 2019-2023
- Stoke Therapeutics revenue 2022-2023
- Alt5 Sigma Corp net income 2019-2023
- Alt5 Sigma Corp liabilities 2019-2023
- Alt5 Sigma Corp revenue 2019-2023
- Lantheus Holdings liabilities 2019-2023
- Larimar Therapeutics liabilities 2019-2023
- Alt5 Sigma Corp operating profit 2019-2023
- Lumos Pharma net cash 2019-2023
- Lexicon Pharmaceuticals net cash 2019-2023
- Amicus Therapeutics total equity 2019-2023
- Lantheus Holdings total equity 2019-2023
- Acer Therapeutics Inc. net income 2018-2022
- Acer Therapeutics Inc. total assets 2018-2022
- Larimar Therapeutics total equity 2019-2023
- Stoke Therapeutics operating profit 2019-2023
- Leap Therapeutics total equity 2019-2023
- Stem Holdings, Inc. operating profit 2019-2023
- Abbvie total equity 2019-2023
- Abbvie operating profit 2019-2023
- Abbvie net income 2019-2023
- Spero Therapeutics operating profit 2019-2023
- Lexicon Pharmaceuticals total assets 2019-2023
- Lumos Pharma total assets 2019-2023
- Abbvie net cash 2019-2023
- Lantern Pharma total assets 2019-2023
- Larimar Therapeutics total assets 2019-2023
- Statera Biopharma, Inc. operating profit 2017-2021
- Leap Therapeutics total assets 2019-2023
- Sorrento Therapeutics operating profit 2018-2022
- Lantheus Holdings total assets 2019-2023
- Leap Therapeutics liabilities 2019-2023
- Statera Biopharma, Inc. revenue 2011-2021
- Acer Therapeutics Inc. operating profit 2018-2022
- Lixte Biotechnology Holdings, Inc. total equity 2019-2023
- Lantheus Holdings revenue 2019-2023
- Lexicon Pharmaceuticals net income 2018-2022
- Lumos Pharma net income 2009-2013
- Lantern Pharma net income 2019-2021
- Springworks Therapeutics net income 2018-2020
- Larimar Therapeutics net income 2019-2023
- Leap Therapeutics net income 2019-2023
- Lipella Pharmaceuticals total equity 2020-2023
- Ligand Pharmaceuticals total equity 2019-2023
- Spero Therapeutics net income 2019-2023
- Sonnet Biotherapeutics Holdings, Inc. total equity 2019-2023
- Sonoma Pharmaceuticals total equity 2019-2023
- Lftd Partners Inc. total equity 2019-2023
- Lannett Company total equity 2018-2022
- Summit Therapeutics total equity 2019-2023
- Sonnet Biotherapeutics Holdings, Inc. total assets 2019-2023
- Landos Biopharma total equity 2019-2023
- Kura Oncology, Inc. total equity 2019-2023
- Solid Biosciences total equity 2019-2023
- Leap Therapeutics revenue 2020-2021
- Lumos Pharma revenue 2019-2023
- Amicus Therapeutics total assets 2019-2023
- Amicus Therapeutics net income 2019-2023
- Amicus Therapeutics net cash 2019-2023
- Amicus Therapeutics gross profit 2019-2023
- Sorrento Therapeutics revenue 2018-2022
- Amicus Therapeutics revenue 2019-2023
- Amicus Therapeutics operating profit 2019-2023
- Amicus Therapeutics liabilities 2019-2023
- Lexicon Pharmaceuticals operating profit 2019-2023
- Lumos Pharma operating profit 2019-2023
- Lantern Pharma operating profit 2021-2023
- Lexicon Pharmaceuticals revenue 2019-2023
- Larimar Therapeutics operating profit 2019-2023
- Spero Therapeutics revenue 2019-2023
- Lantheus Holdings operating profit 2019-2023
- Stoke Therapeutics net income 2019-2023
- Leap Therapeutics operating profit 2019-2023
- Stem Holdings, Inc. net income 2019-2023
- Lantheus Holdings gross profit 2019-2023
- Sorrento Therapeutics net income 2018-2022
- Statera Biopharma, Inc. net income 2017-2021
- Acer Therapeutics Inc. net cash 2018-2022
- Acer Therapeutics Inc. liabilities 2018-2022
- Springworks Therapeutics total equity 2019-2023
- Longeveron operating profit 2020-2023
- Lucira Health liabilities 2020-2021
- Longeveron liabilities 2020-2023
- Lineage Cell Therapeutics liabilities 2019-2023
- Stem Holdings, Inc. total assets 2019-2023
- Statera Biopharma, Inc. total assets 2017-2021